Total Estimated Cost of Diagnosed Diabetes $327 Billion in 2017

Share this content:
Total Estimated Cost of Diagnosed Diabetes $327 Billion in 2017
Total Estimated Cost of Diagnosed Diabetes $327 Billion in 2017

WEDNESDAY, March 28, 2018 (HealthDay News) -- The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion in direct medical costs, according to a study published online March 22 in Diabetes Care.

Under the direction of the American Diabetes Association, Wenya Yang, from The Lewin Group Inc. in Falls Church, Va., and colleagues used a prevalence-based approach to combine the demographics of the U.S. population in 2017 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model.

The researchers note that the total estimated cost of diagnosed diabetes was $327 billion in 2017, which included $237 and $90 billion in direct medical costs and reduced productivity, respectively. Care for people with diagnosed diabetes accounted for 1 in 4 health dollars in the United States; more than half of that expenditure was directly due to diabetes. The average medical expenditures were ~$16,750 per year for people with diagnosed diabetes, with ~$9,600 attributed to diabetes. On average, people with diagnosed diabetes had medical expenditures about 2.3 times higher than expected in the absence of diabetes.

"After adjusting for inflation, economic costs of diabetes increased by 26 percent from 2012 to 2017 due to the increased prevalence of diabetes and the increased cost per person with diabetes," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

CDC: Birth Rate for 10- to-14-Year-Olds at Record ...

Reduction in birth rates for all race and Hispanic origin groups; largest decline in non-Hispanic blacks

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lower mortality seen with lonafarnib monotherapy after 2.2 years compared with no treatment

About 40 Percent of Men Report Experiencing Weight Stigma

About 40 Percent of Men Report Experiencing Weight ...

Experience of weight stigma associated with increased odds of underweight or obesity

is free, fast, and customized just for you!

Already a member?

Sign In Now »